Search - tctmd.com

Displaying 701 - 720 of 840

Sort: Relevancy | Date

Drugs Most Heavily Promoted by Pharma Don’t Necessarily Offer the Best Health Value

News Daily News

Drugs Most Heavily Promoted by Pharma Don’t Necessarily Offer the Best Health Value

May 04, 2017

Visits Nixed: Efforts to Limit Pharma Reps’ Influence Seem to Bear Fruit

News Daily News

Visits Nixed: Efforts to Limit Pharma Reps’ Influence Seem to Bear Fruit

May 02, 2017

Most PAD Patients ‘Dramatically Undertreated’ With Preventive Meds, Lifestyle Counseling

News Daily News

Most PAD Patients ‘Dramatically Undertreated’ With Preventive Meds, Lifestyle Counseling

May 01, 2017

FOURIER in Focus: Costs, Patient Selection, Combination Therapy, and Safety Debated as Lipid Experts Digest the Data

News Conference News EAS 2017

FOURIER in Focus: Costs, Patient Selection, Combination Therapy, and Safety Debated as Lipid Experts Digest the Data

Yael L. Maxwell

April 26, 2017

Is Atherosclerosis an LDL-Cholesterol or Immune Disease? The Answer May Be Both

News Conference News EAS 2017

Is Atherosclerosis an LDL-Cholesterol or Immune Disease? The Answer May Be Both

Yael L. Maxwell

April 25, 2017

Many Patients Prescribed PCSK9 Inhibitors Never End Up Getting Them

News Conference News ACC 2017

Many Patients Prescribed PCSK9 Inhibitors Never End Up Getting Them

Yael L. Maxwell

March 23, 2017

Radiation Exposure Greater for Radial vs Femoral PCI, RAD-MATRIX Dosimeter Study Confirms

News Conference News ACC 2017

Radiation Exposure Greater for Radial vs Femoral PCI, RAD-MATRIX Dosimeter Study Confirms

March 19, 2017

CARAT: Novel HDL Mimetic Fails to Show Benefit in Coronary Atherosclerosis After ACS

News Conference News ACC 2017

CARAT: Novel HDL Mimetic Fails to Show Benefit in Coronary Atherosclerosis After ACS

Yael L. Maxwell

March 18, 2017

Replacing Aspirin With Low-Dose Rivaroxaban for Post-ACS Therapy Appears Safe

News Conference News ACC 2017

Replacing Aspirin With Low-Dose Rivaroxaban for Post-ACS Therapy Appears Safe

March 18, 2017

Rivaroxaban Bests Aspirin for Preventing Recurrence of VTE: EINSTEIN CHOICE

News Conference News ACC 2017

Rivaroxaban Bests Aspirin for Preventing Recurrence of VTE: EINSTEIN CHOICE

March 18, 2017

ORION-1: Novel LDL-Lowering Treatment Could Reduce Costs, Increase Adherence Over PCSK9s

News Conference News ACC 2017

ORION-1: Novel LDL-Lowering Treatment Could Reduce Costs, Increase Adherence Over PCSK9s

Yael L. Maxwell

March 17, 2017

SPIRE 1 and 2: Support for PCSK9 Inhibition but Not Bococizumab

News Conference News ACC 2017

SPIRE 1 and 2: Support for PCSK9 Inhibition but Not Bococizumab

Yael L. Maxwell

March 17, 2017

Timing and Dose Matters When It Comes to Statin Therapy Before CABG Surgery

News Daily News

Timing and Dose Matters When It Comes to Statin Therapy Before CABG Surgery

Michael O'Riordan

March 16, 2017

Mixed Clinical, Biomarker Score Might Boost CAD Risk Prediction

News Daily News

Mixed Clinical, Biomarker Score Might Boost CAD Risk Prediction

Yael L. Maxwell

March 03, 2017

Big Fluctuations in Blood Pressure Signal a Higher Stroke Risk in Well-Controlled Hypertensives

News Conference News ISC 2017

Big Fluctuations in Blood Pressure Signal a Higher Stroke Risk in Well-Controlled Hypertensives

February 24, 2017

DESolve Bioresorbable Stent Compares Well With Absorb but Longer Follow-up Needed

News Daily News

DESolve Bioresorbable Stent Compares Well With Absorb, but Longer Follow-up Needed

Michael O'Riordan

February 16, 2017

HDL Function Improved With Olive Oil-Enriched Mediterranean Diet: PREDIMED Study

News Daily News

HDL Function Improved With Olive Oil-Enriched Mediterranean Diet: PREDIMED Study

Michael O'Riordan

February 14, 2017

Minding the Gaps: Race and Sex Disparities in Rehospitalization Post-MI Might Be Due to Angina, Depression

News Daily News

Minding the Gaps: Race and Sex Disparities in Rehospitalization Post-MI Might Be Due to Angina, Depression

Yael L. Maxwell

February 10, 2017

TAVR Boosts Health Status in Most Patients, But Many Still Suffer Post-Procedure

News Daily News

TAVR Boosts Health Status in Most Patients, but Many Still Suffer Postprocedure

February 06, 2017

How Low Can Cholesterol Go? Safety Not in Limbo for Patients With Very Low LDL on Alirocumab, Study Shows

News Daily News

How Low Can Cholesterol Go? Safety Not in Limbo for Patients With Very Low LDL on Alirocumab, Study Shows

Yael L. Maxwell

January 31, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.